Task: Answer the multiple-choice question.
Question: Which drug exhibits a -13.371% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) Cc1nnc(SCc2cccc(CSc3nnc(C)s3)c2)s1
b) O=C(O)c1ccc(OC(F)(F)C(F)C(F)(F)F)cc1
c) [2H]C([2H])(CCOS(N)(=O)=O)c1ccccc1
d) O=C(O)CCCNS(=O)(=O)c1cccc2nsnc12
Answer: a. Cc1nnc(SCc2cccc(CSc3nnc(C)s3)c2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(SCc2cccc(CSc3nnc(C)s3)c2)s1
Cc1nnc(SCc2cccc(CSc3nnc(C)s3)c2)s1
2-methyl-5-[[3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]phenyl]methylsulfanyl]-1,3,4-thiadiazole